Related Experiment Video
Updated: Nov 8, 2025

Author Spotlight: Improved Localization and Monitoring of Coronary Flow Reserve Using Modified PLAX View in Mice
Published on: August 25, 2023
The Association of a PRECISE-DAPT Score With No-Reflow in Patients With ST-Segment Elevation Myocardial Infarction
Murat Selçuk1, Tufan Çınar1, Faysal Şaylık2
1Department of Cardiology, Sultan II. Abdülhamid Han Training and Research Hospital, Health Sciences University, Istanbul, Turkey.
Insights
The PRECISE-DAPT score, predicting bleeding complications, was significantly higher in ST-elevation myocardial infarction (STEMI) patients who experienced no-reflow after percutaneous coronary intervention (PCI). Higher scores also correlated with worse outcomes.
Area of Science:
- Cardiology
- Interventional Cardiology
- Clinical Research
Background:
- ST-elevation myocardial infarction (STEMI) requires prompt reperfusion therapy.
- Primary percutaneous coronary intervention (PCI) is the standard treatment for STEMI.
- Predicting complications like no-reflow (NR) is crucial for patient management.
Purpose of the Study:
- To assess the association between the PRECISE-DAPT score and the incidence of no-reflow (NR) in STEMI patients undergoing primary PCI.
- To investigate the relationship between the PRECISE-DAPT score and adverse clinical outcomes in this patient cohort.
Main Methods:
- Observational, retrospective study including 335 STEMI patients treated with primary PCI.
- Patients were stratified based on a PRECISE-DAPT score of <25 versus ≥25.
- Multivariable analysis was employed to determine independent predictors of NR.
Main Results:
- No-reflow (NR) occurred in 8.9% of patients.
- Patients who developed NR had a significantly higher mean PRECISE-DAPT score (20.03 vs 11.33; P = .005).
- A PRECISE-DAPT score ≥25 was associated with increased arrhythmic complications, in-hospital shock, and mortality. The score was independently linked to NR (OR: 2.87, P = .015).
Conclusions:
- The PRECISE-DAPT score is a significant predictor of no-reflow (NR) in STEMI patients undergoing primary PCI.
- Higher PRECISE-DAPT scores are associated with increased risk of NR and adverse in-hospital outcomes.
- This study provides novel insights into the utility of the PRECISE-DAPT score beyond bleeding risk prediction.
Abstract:
This study aimed to evaluate the association of admission PREdicting bleeding Complications In patients undergoing Stent implantation and subsEquent Dual Anti Platelet Therapy (PRECISE-DAPT) score with the development of no-reflow (NR) in patients with ST-elevation myocardial infarction (STEMI) treated with primary percutaneous coronary intervention (PCI). In this observational, retrospective study, 335 consecutive STEMI patients who were treated with primary PCI were included. We classified the study population into 2 groups: patients with a PRECISE-DAPT score <25 and those with a PRECISE-DAPT score ≥25. Overall, 30 (8.9%) patients developed NR. The mean PRECISE-DAPT score (20.03 ± 15.32 vs 11.33 ± 12.18; P = .005) was significantly higher in cases who developed NR. Moreover, arrhythmic complications, in-hospital shock, and in-hospital mortality rates were significantly higher in patients with a PRECISE-DAPT score ≥25 compared to those with a PRECISE-DAPT score <25. According to a multivariable analysis, the PRECISE-DAPT score was found to be independently linked with NR (odds ratio: 2.87, with P = .015). To our knowledge, these data are the first in major medical science databases to determine the relationship between the PRECISE-DAPT score and the NR phenomenon in patients with STEMI undergoing primary PCI.
More Related Videos
18:11A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
Published on: December 28, 2012
09:23Confirmation of Myocardial Ischemia and Reperfusion Injury in Mice Using Surface Pad Electrocardiography
Published on: November 24, 2016
Related Concept Videos
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations